Log in to save to my catalogue

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer...

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2336256866

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan

About this item

Full title

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan

Publisher

Singapore: Springer Singapore

Journal title

International journal of clinical oncology, 2020-05, Vol.25 (5), p.912-920

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Purpose
Clinical outcomes of patients with newly diagnosed metastatic hormone-naïve prostate cancer (mHNPC) and initially treated with androgen deprivation therapy (ADT) were evaluated.
Methods
The medical records of 605 consecutive mHNPC patients with initial ADT or combined androgen blockade (CAB) at nine study centers between 2008 and 2...

Alternative Titles

Full title

Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2336256866

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2336256866

Other Identifiers

ISSN

1341-9625

E-ISSN

1437-7772

DOI

10.1007/s10147-019-01614-8

How to access this item